MetaVia, Inc. (MTVA)
1.01
-0.06
(-5.61%)
USD |
NASDAQ |
Nov 20, 16:00
1.00
-0.01
(-0.99%)
After-Hours: 20:00
MetaVia Enterprise Value : -1.808M for Nov. 20, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2026 | -1.808M |
| November 19, 2026 | -1.403M |
| November 18, 2026 | -1.470M |
| November 17, 2026 | -0.1894M |
| November 16, 2026 | -0.4928M |
| November 13, 2026 | 0.1478M |
| November 12, 2026 | 0.1478M |
| November 11, 2026 | 1.092M |
| November 10, 2026 | 1.429M |
| November 09, 2026 | 2.238M |
| November 06, 2026 | 1.024M |
| November 05, 2026 | -1.268M |
| November 04, 2026 | 0.4175M |
| November 03, 2026 | -0.1219M |
| November 02, 2026 | -0.7288M |
| October 30, 2026 | -1.066M |
| October 29, 2026 | -0.5939M |
| October 28, 2026 | -0.9311M |
| October 27, 2026 | -0.8637M |
| October 26, 2026 | -0.4254M |
| October 23, 2026 | 0.6872M |
| October 22, 2026 | 0.7546M |
| October 21, 2026 | 0.4175M |
| October 20, 2026 | 0.0803M |
| October 19, 2026 | -0.3242M |
| Date | Value |
|---|---|
| October 16, 2026 | -0.1219M |
| October 15, 2026 | 0.6198M |
| October 14, 2026 | 0.5523M |
| October 13, 2026 | 1.024M |
| October 12, 2026 | 1.159M |
| October 09, 2026 | 0.8895M |
| October 08, 2026 | 0.4175M |
| October 07, 2026 | 1.227M |
| October 06, 2026 | 1.362M |
| October 05, 2026 | 1.766M |
| October 02, 2026 | 1.766M |
| October 01, 2026 | 1.766M |
| September 30, 2026 | 1.968M |
| September 29, 2026 | -1.541M |
| September 28, 2026 | -1.476M |
| September 25, 2026 | -1.541M |
| September 24, 2026 | -1.739M |
| September 23, 2026 | -1.739M |
| September 22, 2026 | -1.410M |
| September 21, 2026 | -1.476M |
| September 18, 2026 | -1.081M |
| September 17, 2026 | -2.002M |
| September 16, 2026 | -2.330M |
| September 15, 2026 | -2.067M |
| September 14, 2026 | -1.804M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.052B |
| Alnylam Pharmaceuticals, Inc. | 18.66B |
| Anika Therapeutics, Inc. | 158.39M |
| Savara, Inc. | 776.30M |
| Arrowhead Pharmaceuticals, Inc. | 6.053B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.623M |
| Total Expenses (Quarterly) | 4.623M |
| EPS Diluted (Quarterly) | -0.6921 |
| Earnings Yield | -317.9% |
| Normalized Earnings Yield | -320.47 |